My Cart

Human BAFF / BAFFR Inhibitor Screening Kit (TR-FRET)AI Compatible

Customer Reviews
Cat. No. / Size
Price
Availability
Qty
FRT-P036-100tests
$770.00
In Stock - Delivery in 2-3 weeks
FRT-P036-500tests
$2080.00
In Stock - Delivery in 2-3 weeks
Sub-Total$ 0

Product Details

  • FAB

    1. Comprehensive validation - Validated with various antibody drugs.
    2. Simple and fast operation - No complicated washing steps, significantly reducing time.
    3. High batch consistency - Strict control over raw materials and finished product quality, ensuring a stable supply.
    4. Accurate and reliable results - High sensitivity with minimal matrix effects.
    5. High throughput capability - Support multiple product specifications, ideal for high-throughput screening.
    6. Fast completion - Results in just 1 hour.
  • Product Specifications

    Assay Type
    Competition-TR-FRET
    Reactivity
    Human
    Regulatory Status
    RUO
    Assay Time
    1 hr
    Sample volume
    10 μL

  • Product Overview

    The Human BAFF / BAFFR Inhibitor Screening Kit (TR-FRET) is based on a homogeneous (no wash) competition TR-FRET technology (Time-Resolved Fluorescence Resonance Energy Transfer) to screen for inhibitors of human BAFF binding to BAFFR within one hour. It can also be used as a universal detection tool to identify the ability of human BAFF to bind to human BAFFR.

  • Storage

    1. Store the unopened kit at 2-8°C upon receipt.

    2. Locate the expiration date on the outer packaging and do not use reagents beyond their expiration date.

    3. The opened kit should be stored according to the storage conditions listed in the Components Table. The shelf life of the opened kit is 30 days from the date of opening.

  • Materials Provided

    ID
    Components
    Size
    FRTP036-C01
    Human BAFFR Protein Europium-chelate
    100 tests/500 tests
    FRTP036-C02
    FA Labeled Human BAFF Protein
    100 tests/500 tests
    FRTP036-C03
    Anti-BAFF Neutralizing Antibody
    30 μg/100 tests
    150 μg/500 tests
    DB-04
    TR-FRET Sample Dilution Buffer, pH7.4
    50 mL/100 tests & 500 tests
    DB-05
    TR-FRET Detection Buffer, pH7.4
    50 mL/100 tests & 500 tests

  • Assay Principles

    This Human BAFF / BAFFR Inhibitor Screening Kit (TR-FRET) is based on TR-FRET technology (Time-Resolved Fluorescence Resonance Energy Transfer). This assay uses the mixture of biotinylated human BAFFR and Europium-chelate labeled streptavidin as the Donor and FA Labeled Human BAFF Protein as the Acceptor.

    — When the sample does not contain the inhibitors that block the binding of human BAFF to human BAFFR, the Donor and Acceptor are in close proximity because of the binding of human BAFF and human BAFFR. Upon Donor excitation with light of a specific wavelength (337 nm), in addition to Donor emission (620 nm), non-radiative transfer of energy occurs between Donor and Acceptor, resulting in Acceptor emission (665 nm).

    — When the sample contains the inhibitors that block the binding of human BAFF to human BAFFR, the components inhibit the binding between the Donor and Acceptor and thereby prevent FRET from occurring.

    Assay Principles
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Bioactivity-TR-FRET 

    Please refer to DS document for the assay protocol.

     BAFF TR-FRET

    In this TR-FRET assay, Human BAFFR Protein Europium-chelate is used as the Donor and FA Labeled Human BAFF Protein is used as the Acceptor. An inhibition Assay was performed to evaluate the interaction between human BAFFR and human BAFF using Anti-BAFF Neutralizing Antibody resulting in a typical IC50 of 0.4001 nM (QC tested).

  •  BAFF TR-FRET

    In this TR-FRET assay, Human BAFFR Protein Europium-chelate is used as the Donor and FA Labeled Human BAFF Protein is used as the Acceptor. An inhibition Assay was performed to evaluate the interaction between human BAFFR and human BAFF using Anti-BAFF Neutralizing Antibody resulting in a typical IC50 of 0.4001 nM (QC tested).

Customer Reviews
Writing Reviews

Recent Advances

 
Drug Development Progress
  • English Name:

    B-cell-activating factor/B lymphocyte stimulator

  • Category:

  • Approved Drugs:

    2 Details

  • Drugs in Clinical Trials:

    8 Details

  • Highest Development Stage:

    Approved

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews